Evidence map›Paper›PMID 31194870›Full record

ArticleNucleic acids research2019

Two factor authentication: Asf1 mediates crosstalk between H3 K14 and K56 acetylation.

Joy M Cote, Yin-Ming Kuo, Ryan A Henry, Hataichanok Scherman, Daniel D Krzizike, Andrew J Andrews

Open access · goldAbstract read
In one paragraph

Article in Nucleic acids research, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 26 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Joy M CoteDepartment of Cancer Biology, Fox Chase Cancer Center, Philadelphia, PA 19111, USA.
Yin-Ming KuoDepartment of Cancer Biology, Fox Chase Cancer Center, Philadelphia, PA 19111, USA.
Ryan A HenryDepartment of Chemistry and Biochemistry, Wilkes University, Wilkes-Barre, PA 18766, USA.
Hataichanok SchermanThe Histone Source, Department of Biochemistry and Molecular Biology, Colorado State University, Fort Collins, CO 80523, USA.
Daniel D KrzizikeDepartment of Cancer Biology, Fox Chase Cancer Center, Philadelphia, PA 19111, USA.
Andrew J AndrewsDepartment of Cancer Biology, Fox Chase Cancer Center, Philadelphia, PA 19111, USA.
Fox Chase Cancer Center · USColorado State University · USWilkes University · US

Funding

TRAINING PROGRAM IN CANCER RESEARCHT32CA009035 · NCI · RESEARCH INST OF FOX CHASE CAN CTR · PI CHERNOFF, JONATHAN · 1985 to 2020
$10.5M
The Role of Histone Chaperones in Histone Acetylation and Nucleosome DynamicsR01GM102503 · NIGMS · UNIVERSITY OF NORTH CAROLINA WILMINGTON · PI ANDREWS, ANDREW JOSEPH · 2014 to 2023
$3.9M
NCI NIH HHS T32 CA009035NIGMS NIH HHS R01 GM102503
6 · The paper itself

Abstract

The ability of histone chaperone Anti-silencing factor 1 (Asf1) to direct acetylation of lysine 56 of histone H3 (H3K56ac) represents an important regulatory step in genome replication and DNA repair. In Saccharomyces cerevisiae, Asf1 interacts functionally with a second chaperone, Vps75, and the lysine acetyltransferase (KAT) Rtt109. Both Asf1 and Vps75 can increase the specificity of histone acetylation by Rtt109, but neither alter selectivity. However, changes in acetylation selectivity have been observed in histones extracted from cells, which contain a plethora of post-translational modifications. In the present study, we use a series of singly acetylated histones to test the hypothesis that histone pre-acetylation and histone chaperones function together to drive preferential acetylation of H3K56. We show that pre-acetylated H3K14ac/H4 functions with Asf1 to drive specific acetylation of H3K56 by Rtt109-Vps75. Additionally, we identified an exosite containing an acidic patch in Asf1 and show that mutations to this region alter Asf1-mediated crosstalk that changes Rtt109-Vps75 selectivity. Our proposed mechanism suggests that Gcn5 acetylates H3K14, recruiting remodeler complexes, allowing for the Asf1-H3K14ac/H4 complex to be acetylated at H3K56 by Rtt109-Vps75. This mechanism explains the conflicting biochemical data and the genetic links between Rtt109, Vps75, Gcn5 and Asf1 in the acetylation of H3K56.

Indexed as

AcetylationCell Cycle ProteinsHistone AcetyltransferasesHistonesLysineMolecular ChaperonesMutationp300-CBP-Associated FactorProtein BindingProtein Processing, Post-TranslationalSaccharomyces cerevisiaeSaccharomyces cerevisiae ProteinsSubstrate SpecificityASF1 protein, S cerevisiaeCell Cycle ProteinsGCN5 protein, S cerevisiaeHistone AcetyltransferasesHistonesLysineMolecular Chaperonesp300-CBP-Associated FactorRtt109 protein, S cerevisiaeSaccharomyces cerevisiae ProteinsVps75 protein, S cerevisiae

Identifiers

PMID31194870
PMCPMC6698667
OpenAlexW2951467099

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.